Scalpel, Sutures, and Separation Notices

• by Kerri Miller

• January 6, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

• by Kathryn Wighton

• June 29, 2026

• 3 min

Application and advantages of intrathoracic paravertebral block in uniportal video-assisted thoracoscopic surgery

• by Zhengjun Li, Siwei Chao, Shuai Ma, Ding Li, Chang Liu, Sibo You, Guofeng Zhang, Xiangchao Zhang, Shiyuan Song, Tao Wang, Yi Ren

• July 2, 2026

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

• by Conexiant News Staff

• July 10, 2026

• 7 min